Details for New Drug Application (NDA): 214835
✉ Email this page to a colleague
The generic ingredient in RISVAN is risperidone. There are thirty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the risperidone profile page.
Summary for 214835
Tradename: | RISVAN |
Applicant: | Labs Farms Rovi Sa |
Ingredient: | risperidone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 214835
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | 75MG | ||||
Approval Date: | Mar 29, 2024 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | Strength | 100MG | ||||
Approval Date: | Mar 29, 2024 | TE: | RLD: | Yes |
Complete Access Available with Subscription